Skip to main content

LMAT

Stock
Health Care
Medical Instruments & Supplies

Performance overview

LMAT Price
Price Chart

Forward-looking statistics

Beta
0.62
Risk
33.75%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.

Company info

SectorHealth Care
IndustryMedical Instruments & Supplies
Employees520
Market cap$1.7B

Fundamentals

Enterprise value$1.8B
Revenue$226.3M
Revenue per employee—
Profit margin19.96%
Debt to equity53.33

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$1.97
Dividend per share$0.80
Revenue per share$10.05
Avg trading volume (30 day)$14M
Avg trading volume (10 day)$14M
Put-call ratio—

Macro factor sensitivity

Growth-0.9
Credit+5.5
Liquidity+0.8
Inflation-4.5
Commodities-0.9
Interest Rates-0.8

Valuation

Dividend yield0.95%
PEG Ratio38.89
Price to sales8.43
P/E Ratio38.89
Enterprise Value to Revenue7.78
Price to book5.49

Upcoming events

Next earnings dayMay 2, 2025
Next dividend day—
Ex. dividend dayMay 15, 2025

News

LeMaitre Vascular (LMAT) Lags Q1 Earnings Estimates

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.48 per share, missing the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.44 per share a year ago.

Zacks Investment Research (May 1, 2025)
Julie Biel shares her 2025 small cap picks

CNBC guest trader Julie Biel shares her 2025 small cap picks.

CNBC Television (December 26, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free